N-decanoyl-D-erythro-sphingosine
| Catalog Number | BL-M001043 |
| CAS Number | 111122-57-7 |
| Description | N-decanoyl-D-erythro-sphingosine, a synthesized ceramide derivative, exhibits promising anti-neoplastic activity. Research suggests its efficacy in triggering apoptotic pathways in malignant cells while impeding neoplastic proliferation. Its exploration in oncology delineates a burgeoning interest in exploiting sphingolipid analogs for therapeutic interventions. |
 | |
| IUPAC Name | N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]decanamide |
| Synonyms | N-(decanoyl)-sphing-4-enine; C10 Ceramide (d18:1/10:0) |
| Molecular Weight | 453.74 |
| Molecular Formula | C28H55NO3 |
| Boiling Point | 616.0±55.0 °C at 760 mmHg |
| Purity | 95% |
| Density | 0.9±0.1 g/cm3 |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 74.12%, H 12.22%, N 3.09%, O 10.58% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(CO)NC(=O)CCCCCCCCC)O |
| InChI | InChI=1S/C28H55NO3/c1-3-5-7-9-11-12-13-14-15-16-18-19-21-23-27(31)26(25-30)29-28(32)24-22-20-17-10-8-6-4-2/h21,23,26-27,30-31H,3-20,22,24-25H2,1-2H3,(H,29,32)/b23-21+/t26-,27+/m0/s1 |
| InChI Key | FDWVAQFAMZLCAX-NBNLIBPQSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
